Orion and Gedeon Richter unite for CNS goal
This article was originally published in Scrip
Executive Summary
With the aim of sharing both cost and risk, Finland's Orion Corporation and Hungarian firm Gedeon Richter have entered into a collaboration agreement for the discovery and development of new chemical entities in the field of cognitive disorders.